Literature DB >> 11901451

Prevalence of functional bowel disorders and related health care seeking: a population-based study.

A Icks1, B Haastert, P Enck, W Rathmann, G Giani.   

Abstract

OBJECTIVES: There are few population-based studies on prevalence of functional bowel disorders (FBD) and related health care seeking. The aim of the present study was to evaluate the prevalence of FBD in a population-based sample and to assess FBD-related health care seeking and medication in Germany. MATERIAL: Cross-sectional study, based on an age- and sex-stratified random sample of 2,400 subjects aged 21-80 years in Düsseldorf, Germany (about 500,000 population). Assessment was performed using a postal written questionnaire.
METHODS: Prevalence of gastrointestinal pain or discomfort in the past 12 months was assessed, in particular, lower abdominal pain and irritable bowel syndrome (IBS). Furthermore, health care seeking and medication (prescribed and over-the-counter) due to FBD was assessed. Multiple logistic regression (survey estimated) was performed to evaluate associations of FBD with age, sex, and the socioeconomic status (SES).
RESULTS: 1,281 subjects (53.4 %) were analyzed. Standardized prevalences were 22.6 % (95 %-CI: 20.3 - 25.1 %) for lower abdominal pain and 12.5 % (10.7-14.5 %) for IBS. Both lower abdominal pain and IBS were significantly less frequent in the older population compared to younger subjects. No significant differences were found for gender and SES. Among subjects with lower abdominal pain and IBS, 55.1 % and 49.3 % reported health care seeking due to their GI disorders, and 63.9 % and 56.2 % reported use of medication, respectively.
CONCLUSIONS: A high prevalence of functional bowel disorders was found in this population-based study in Germany. Only about half of the subjects reported health care seeking due to their bowel disorders. Self-medication with over-the-counter agents was frequently performed.

Entities:  

Mesh:

Year:  2002        PMID: 11901451     DOI: 10.1055/s-2002-22324

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  13 in total

1.  Irritable bowel syndrome and other gastrointestinal disorders: evaluating self-medication in an Asian community setting.

Authors:  Chong-Han Kua; Siow-Tian Ng; Reshma Lhode; Stefan Kowalski; Kok-Ann Gwee
Journal:  Int J Clin Pharm       Date:  2012-05-03

2.  Post-infectious irritable bowel syndrome (PI-IBS) after infection with Shiga-like toxin-producing Escherichia coli (STEC) O104:H4: A cohort study with prospective follow-up.

Authors:  Viola Andresen; Bernd Löwe; Wiebke Broicher; Björn Riegel; Katharina Fraedrich; Moritz von Wulffen; Kerrin Gappmayer; Karl Wegscheider; András Treszl; Matthias Rose; Peter Layer; Ansgar W Lohse
Journal:  United European Gastroenterol J       Date:  2015-04-28       Impact factor: 4.623

3.  The Prevalence, Comorbidity, Management and Costs of Irritable Bowel Syndrome.

Authors:  Winfried Häuser; Ursula Marschall; Peter Layer; Thomas Grobe
Journal:  Dtsch Arztebl Int       Date:  2019-07-08       Impact factor: 5.594

4.  Association of gluten enteropathy and irritable bowel syndrome in adult Turkish population.

Authors:  Kamil Ozdil; Mehmet Sokmen; Ozdal Ersoy; Huseyin Demirsoy; Besir Kesici; Cetin Karaca; Nihat Akbayir; Levent Erdem; Canan Alkim; Damlanur Sakiz
Journal:  Dig Dis Sci       Date:  2008-02-13       Impact factor: 3.199

5.  An extended assessment of bowel habits in a general population.

Authors:  Gabrio Bassotti; Massimo Bellini; Filippo Pucciani; Renato Bocchini; Antonio Bove; Pietro Alduini; Edda Battaglia; Paolo Bruzzi
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

Review 6.  Irritable bowel syndrome and chronic pelvic pain: a singular or two different clinical syndrome?

Authors:  Anna Matheis; Ute Martens; Johannes Kruse; Paul Enck
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

Review 7.  [Irritable bowel syndrome].

Authors:  W Häuser; M Lempa
Journal:  Schmerz       Date:  2004-04       Impact factor: 1.107

8.  Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors.

Authors:  Moritz von Wulffen; Nicholas J Talley; Johann Hammer; Jessica McMaster; Graeme Rich; Ayesha Shah; Natasha Koloski; Bradley J Kendall; Mike Jones; Gerald Holtmann
Journal:  Dig Dis Sci       Date:  2018-10-27       Impact factor: 3.199

9.  Silicea gastrointestinal gel improves gastrointestinal disorders: a non-controlled, pilot clinical study.

Authors:  B Uehleke; M Ortiz; R Stange
Journal:  Gastroenterol Res Pract       Date:  2012-03-04       Impact factor: 2.260

Review 10.  Guidelines on the irritable bowel syndrome: mechanisms and practical management.

Authors:  R Spiller; Q Aziz; F Creed; A Emmanuel; L Houghton; P Hungin; R Jones; D Kumar; G Rubin; N Trudgill; P Whorwell
Journal:  Gut       Date:  2007-05-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.